CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT04886492
Status
Enrolling By Invitation

Conditions

  • Neuromyelitis Optica Spectrum Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a Prospective, observational research study for patients with NMOSD under the care of a licensed neurologist. Approximately 800 patients and 35 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

Key Dates

Start date
Apr 28, 2021
Status verified
Jan 2026
Primary completion
Jan 31, 2099
Completion
Jan 31, 2099

Study Design

Enrollment
800 participants (estimated)

Arms

  • Arm: NMO
    Pts presenting to enrolling sites across the northern America are invited to enroll if eligible

Primary Outcome Measure

NMO epidemiology, presentation, natural history, management, and outcomes [ Time Frame: A minimum of 10 years from last patient enrolled ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By research site
CorEvitas, LLC· Waltham, MA

Related Studies